4
Changes in Ownership
Arcus Biosciences, Inc. Filed Acc 0001724521-24-000009
Chief Financial Officer sold 2,004 shares at $20.00 ($40,080)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Goeltz II Robert C. · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-01-02 | Sale : show line 1 in the form 10b5-1 | −2,004 | $20.00 | $40,080 | 51,831 | D |
| Open-market sales · 2,004 sh · avg $20.00 · $40,080 | ||||||
Loading xslF345X05/wk-form4_1704406978.xml…